Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — Retroperitoneal lymph node dissection conferred favorable survival rates among men with ...
First-Line, Fixed-Duration Nivolumab Plus Ipilimumab Followed by Nivolumab in Clinically Diverse Patient Populations With Unresectable Stage III or IV Melanoma: CheckMate 401 Patients who underwent ...
Patients with advanced testicular cancer occasionally require repeat retroperitoneal lymph node dissection (RPLND) due to incomplete resection or recurrence of retroperitoneal masses. Heidenreich et ...
Luca Antonelli, MD; Davide Ardizzone, MD; Isamu Tachibana, MD; Nabil Adra, MD; Clint Cary, MD; Lee Hugar, MD; Wade J. Sexton, MD; Aditya Bagrodia, MD; Michal Mego, MD ...
A 22-year-old man underwent right radical orchiectomy for a testicular mass; the histopathological diagnosis was pure teratoma of the testis. Computed Tomography (CT) with contrast material of the ...
Researchers found that adding retroperitoneal lymphadenectomy to cytoreductive surgery did not improve survival among patients with advanced ovarian cancer. The addition of retroperitoneal ...
Results from the PHENIX-I trial support skipping pelvic lymphadenectomy in women with early cervical cancer who have a negative sentinel lymph node biopsy. Omitting pelvic lymphadenectomy in these ...
On the basis of National Comprehensive Cancer Network guidelines, clinical stage (CS) II seminoma is treated with radiotherapy or chemotherapy. Primary retroperitoneal lymph node dissection (RPLND) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback